Pediatrix Medical Q4 Earnings Miss Estimates Despite Declining Costs

Key Takeaways Pediatrix Medical Group's Q4 EPS of 50 cents missed estimates as revenues fell 1.7% year over year.MD saw 4% same-unit revenue growth, driven by 6.7% gains in reimbursement-related factors.MD sees 2026 EBITDA outlook at $280-$300M and repurchased 4.1M shares in 2025.Pediatrix Medical Group, Inc. (MD) reported fourth-quarter 2025 adjusted earnings per share (EPS) of 50 cents, which missed the Zacks Consensus Estimate by 4.9%. The bottom line declined 2% year over year.Net revenues decreased 1.7 ...